Table 1.
List of pharmacological agents known to affect splicing evaluated in this report.
| No | Pharmacological agent name | Mechanism | Reference |
|---|---|---|---|
| 1 | Aclarubicin | Topo 1 | 21 |
| 2 | Camphothecin | Topo 1 | 22 |
| 3 | Cantharidin | PP1 inhibition | 23 |
| 4 | Dexamethasone | Coupling of transcription and splicing | 24 |
| 5 | Digoxin | Change in ion gradient | 12 |
| 6 | Etoposide | Topo II inhibition | 22 |
| 7 | 5‐(N‐ethyl‐N‐isopropyl) amiloride (EIPA) | Change in ion gradient | 25 |
| 8 | Sodium butyrate | HDAC inhibitor | 11 |
| 9 | Valproic Acid | HDAC inhibitor | 26 |
| 10 | 5‐iodotubercidin | Adenosine kinase inhibitor | 12 |
| 11 | Tyrphostin‐9 | Kinase inhibitor | 12 |